PPAR Gamma Receptor: A Novel Target to Improve Morbidity in Preterm Babies

Worldwide, three-quarters of a million babies are born extremely preterm (<28 weeks gestation) with devastating outcomes: 20% die in the newborn period, a further 35% develop bronchopulmonary dysplasia (BPD), and 10% suffer from cerebral palsy. Pioglitazone, a Peroxisome Proliferator Activated Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Victor, Suresh, Forbes, Ben, Greenough, Anne, Edwards, A. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675178/
https://www.ncbi.nlm.nih.gov/pubmed/38004396
http://dx.doi.org/10.3390/ph16111530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675178/
https://www.ncbi.nlm.nih.gov/pubmed/38004396
http://dx.doi.org/10.3390/ph16111530

Ejemplares similares